Eckert & Ziegler, DE0005659700

Eckert & Ziegler stock holds steady as radiopharma demand builds

Published on 07/10/2026 at 15:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Eckert & Ziegler stock reflects a diagnostics and therapy supplier with exposure to radiopharmaceuticals, sterilization, and medical isotopes. The company is listed in Germany and trades on Xetra.

Eckert & Ziegler, DE0005659700, Illustration mit AI erstellt.
Eckert & Ziegler, DE0005659700, Illustration mit AI erstellt.

Eckert & Ziegler AG (ISIN DE0005659700) is a German medical-technology supplier focused on radiopharmaceuticals, isotopes, and related services. The company trades on Xetra, giving investors a direct listed way to track the stock on a major European venue.

Business mix

The group's model centers on products and services used in nuclear medicine, industrial radiation applications, and other specialist healthcare workflows. That structure gives Eckert & Ziegler a narrower, more technical profile than broader medtech peers, with revenue tied to regulated applications rather than consumer demand.

For investors, that specialization matters because the business mix can make operating performance more sensitive to manufacturing execution, regulatory approvals, and demand trends in radiopharma than to the broader healthcare cycle. It also gives the stock a distinct place in the European life-science supply chain.

Market context

Eckert & Ziegler shares are watched through the lens of European healthcare and industrial exposure, while the company's German listing keeps valuation and trading context tied to the home market. The stock's appeal is therefore less about scale and more about niche positioning in a field where isotope supply and medical uses remain structurally important.

That niche profile is the article's key interpretive point: compared with large-cap medtech names, Eckert & Ziegler offers a more concentrated exposure to radiopharmaceutical demand and production capability. A company with that mix can look different from the wider healthcare sector even when headline market conditions are similar.

Representative product

A representative part of the business is the production and supply of radioisotopes used in medicine and other controlled applications. This is the kind of product set that links the company to specialist labs, clinics, and industrial customers rather than mass-market buyers.

Stock snapshot

Eckert & Ziegler AG trades on Xetra in euros. As of July 10, 2026, no quoted price was included in the available source set.

Fact box

  • Company: Eckert & Ziegler AG
  • ISIN: DE0005659700
  • Ticker: EZ1
  • Exchange: Xetra
  • Sector / Industry: Health Care / Health Care Equipment & Supplies
  • Price (as of July 10, 2026, 1:32 p.m. ET): n/a

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE0005659700 | ECKERT & ZIEGLER | boerse | 69737921 | bgmi